These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24090517)

  • 21. Idiopathic dysautonomia treated with intravenous gammaglobulin.
    Heafield MT; Gammage MD; Nightingale S; Williams AC
    Lancet; 1996 Jan; 347(8993):28-9. PubMed ID: 8531546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute dysautonomia: complete recovery after two courses of IVIg.
    Ishitobi M; Haginoya K; Kitamura T; Munakata M; Yokoyama H; Iinuma K
    Brain Dev; 2004 Dec; 26(8):542-4. PubMed ID: 15533658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute idiopathic dysautonomia: electrophysiology and response to intravenous immunoglobulin.
    Quan D; Rich MM; Bird SJ
    Neurology; 2000 Feb; 54(3):770-1. PubMed ID: 10680827
    [No Abstract]   [Full Text] [Related]  

  • 24. Multiple cranial nerve dysfunction caused by neurosarcoidosis.
    Loor RG; van Tongeren J; Derks W
    Am J Otolaryngol; 2012; 33(4):484-6. PubMed ID: 22154016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurosarcoidosis: rare initial presentation with seizures and delirium.
    Besur S; Bishnoi R; Talluri SK
    QJM; 2011 Sep; 104(9):801-3. PubMed ID: 21051482
    [No Abstract]   [Full Text] [Related]  

  • 26. Neurosarcoidosis: diagnostic approaches and therapeutic strategies.
    Segal BM
    Curr Opin Neurol; 2013 Jun; 26(3):307-13. PubMed ID: 23571775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of acute pandysautonomia with intravenous immunoglobulin.
    Mericle RA; Triggs WJ
    J Neurol Neurosurg Psychiatry; 1997 May; 62(5):529-31. PubMed ID: 9153616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of refractory neurosarcoidosis with TNF-inhibitors: what lies ahead?
    Ahmadzai H; Kiernan MC; Wakefield D; Thomas PS
    Intern Med J; 2012 Feb; 42(2):232. PubMed ID: 22356508
    [No Abstract]   [Full Text] [Related]  

  • 29. Reply: Treatment of refractory neurosarcoidosis with tumour necrosis factor inhibitors--what lies ahead?
    Pereira JA; Anderson NE
    Intern Med J; 2012 Apr; 42(4):478-9. PubMed ID: 22498131
    [No Abstract]   [Full Text] [Related]  

  • 30. Intravenous immunoglobulin treatment in neurologic disorders: yes.
    Sorensen PS
    Arch Neurol; 1999 Aug; 56(8):1025-7. PubMed ID: 10448812
    [No Abstract]   [Full Text] [Related]  

  • 31. [Neurosarcoidosis--different manifestations].
    Magyari M; Frederiksen J
    Ugeskr Laeger; 2010 Nov; 172(48):3344-5. PubMed ID: 21118667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progressive meningoencephalitis due to neurosarcoidosis.
    Adamec I; Ozretić D; Zadro I; Habek M
    Clin Neurol Neurosurg; 2013 Jun; 115(6):793-5. PubMed ID: 22841014
    [No Abstract]   [Full Text] [Related]  

  • 33. Cyclophosphamide for the treatment of central neurosarcoidosis: Retrospective study in 32 patients.
    Bigot W; Chapelon-Abric C; Mangin O; Champion K; Mouly S; Cacoub P; Sène D
    Joint Bone Spine; 2023 May; 90(3):105513. PubMed ID: 36528334
    [No Abstract]   [Full Text] [Related]  

  • 34. Neurosarcoidosis. A report of ten patients illustrating some usual and unusual manifestations.
    Sharma OP; Anders A
    Sarcoidosis; 1985 Sep; 2(2):96-106. PubMed ID: 3031791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of central nervous system sarcoidosis, presenting with psychomotor seizure].
    Maeda J; Moriwaki Y; Tamura S; Hada T; Higashino K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Nov; 30(11):2002-6. PubMed ID: 1484441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Case of central neurosarcoidosis with panhypopituitalism].
    Shimaoka Y; Tajima S; Koshio N; Fujimori F; Tsubata C; Koya T; Moriyama H; Terada M; Takada T; Gejyo F; Hasegawa T; Suzuki E
    Nihon Kokyuki Gakkai Zasshi; 2008 Oct; 46(10):814-9. PubMed ID: 19044032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is the routine use of intravenous immunoglobulin treatment in neurologic disorders justified? No.
    Karussis D; Abramsky O
    Arch Neurol; 1999 Aug; 56(8):1028-32. PubMed ID: 10448813
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diabetes insipidus due to neurosarcoidosis].
    Skowasch D; Pabst S; Wilhelm K; Grohé C
    Pneumologie; 2011 Aug; 65(8):496-7. PubMed ID: 21544752
    [No Abstract]   [Full Text] [Related]  

  • 39. [Neurosarcoidosis].
    Iizuka T; Sakai F
    Nihon Rinsho; 2002 Sep; 60(9):1785-93. PubMed ID: 12233076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autonomic neuropathy improving after intravenous immunoglobulin therapy.
    Alberti C; Spagliardi J; Barbic F; Doneddu PE; Cutellè C; Furlan R; Nobile-Orazio E
    Clin Auton Res; 2024 Apr; 34(2):311-316. PubMed ID: 38733551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.